SALT LAKE CITY, Feb. 13, 2013 /PRNewswire/ -- Remedy Informatics today announced that it is the first vendor authorized by the Center for International Blood & Marrow Transplant Research (CIBMTR) to submit all CIBMTR forms currently supported by CIBMTR's AGNIS system. This achievement represents a significant milestone in Remedy's efforts to help its clients improve clinical outcomes for BMT patients by giving BMT centers the tools necessary to easily access and analyze clinical data.
Remedy officially launched its "Live In Five" program, committing to deploy a fully functional instance of ComprehensiveBMT throughout a BMT center in only five business days.
"The purpose of Remedy Informatics' clinical products is to support our clients' efforts to improve patient care by providing software solutions that will accelerate both clinical research and quality improvement initiatives — that is the central focus of ComprehensiveBMT," said Jonathan Dewey, MD, director of clinical products at Remedy Informatics. "Furthermore, our new five-day deployment strategy has already enabled our clients to derive benefits almost immediately. This is unlike traditional institution-wide software installations and deployments that can take months or years, and are often mired in red tape along the way."
Dr. Douglas Rizzo, CIBMTR's Associate Scientific Director for Data Operations and CIBMTR Executive Committee member, corroborated Remedy's claim. "Remedy Informatics has demonstrated the ability to submit data for all CIBMTR forms currently supported by the AGNIS system, and is now authorized by the CIBMTR for this activity in AGNIS," said Rizzo. "Expanded forms submission by Remedy represents one of several examples of increasing utilization of the AGNIS application to automate data exchange with the CIBMTR for the benefit of transplant centers and researchers."
In addition, Remedy Informatics offers a version of its Investigate™ product, specially designed for Cell Therapy labs. InvestigateCT™ is an integrated research management system designed to provide BMT and cell therapy laboratories an end-to-end service line production and research system. InvestigateCT operationalizes cell products biobanking, cell processing laboratory protocols and research study management, all on the same Mosaic™ Platform as ComprehensiveBMT. Which means that both products are automatically able to share data, annotations, results and gain a composite view of each patient, subject or donor.
"The value of integrating the BMT service line with cell therapy researchers, labs and biobanks is essential to an enterprise seeking to maximize treatment effectiveness and research investment," said Hank Wu, director of translational informatics at Remedy Informatics. "The combination of ComprehensiveBMT and InvestigateCT facilitates multidirectional flow of data, beginning at the patient's initial admission and evaluation and continuing throughout and after the transplantation procedure, allowing researchers to analyze the entire longitudinal view for new findings that can improve outcomes for current and future patients. This is a tangible way to realize the promise of personalized medicine."
"The traditional data process largely fails to use data from one patient to benefit the next, or to utilize clinical data to inform laboratory research and vice versa," said Dewey. "One of our goals is to introduce a new, fully integrated data paradigm for BMT centers and cell therapy labs around the world."
Remedy Informatics will demo both ComprehensiveBMT and InvestigateCT at the 2013 BMT Tandem Meeting held in the Salt Palace in Salt Lake City, Booth #101. Attendees can also participate in Remedy's "Try Then Buy" campaign in order to "test drive" ComprehensiveBMT prior to purchasing the software.
Remedy's cutting-edge BMT research and reporting software serves clients around the world, including the Huntsman Cancer Institute at the University of Utah, Princess Margaret Hospital, The Jewish – Mercy Health BMT Center, and Primary Children's Medical Center in Salt Lake City, UT. Remedy Informatics products were also recently chosen as the technology solution for the European Group for Blood and Marrow Transplantation (EBMT) Registry Upgrade Project.
To request a demo or to learn more about ComprehensiveBMT and how it can benefit your BMT or cancer treatment center, please visit the product page on our website, http://www.remedyinformatics.com/product/comprehensivebmt/.
About Remedy Informatics, Inc.
Remedy Informatics, Inc. is the leading provider of clinical registries, medical research software and research informatics products that accelerate translational medicine discoveries from bench to bedside. Remedy offers a wide range of configurable "off the shelf" biomedical informatics products that are built on the powerful Mosaic™ Platform. Remedy's mission is to tangibly, measurably and permanently improve the effectiveness of life science research and healthcare delivery in the United States and across the globe. For more information visit: www.remedyinformatics.com.
Kristofer Beldin, Remedy Informatics, (801) 870-9407 (cell), email@example.com
SOURCE Remedy Informatics, Inc.